Back
GlaxoSmithKline logo

GlaxoSmithKline Settlement

Canadians prescribed Paxil during pregnancy who allege birth defects may qualify for compensation under a court-approved national settlement.

Opening soonDeadline: Pending court decisionEst. payout: C$2,000 - $40,000Deadline pending

About this settlement

Alleged failure to warn of birth defect risks associated with Paxil use during pregnancy.

A national class action settlement was approved relating to claims that Paxil and Paxil CR caused certain birth defects when taken during pregnancy. Compensation is distributed through a court-supervised claims and points system.

Who qualifies

  • Individuals prescribed Paxil or Paxil CR in Canada
  • Alleged birth defects linked to prenatal exposure
  • Approved eligible claimants under court review

C$2,000 - $40,000

Deadline Pending court decision

View Requirements